1,114 filings
Page 2 of 56
8-K
ydxldp04bcx3or08
10 Jan 24
Pfizer Recommends Shareholders Reject the Below-Market Mini-Tender Offer by TRC Capital Investment Corporation
4:38pm
8-K/A
gy491da0el8j 4zgxi43
14 Dec 23
Pfizer Completes Acquisition of Seagen
5:04pm
8-K
vbg0ujbkxx 5pyj1fs
14 Dec 23
Pfizer Completes Acquisition of Seagen
7:51am
8-K
h38fdx6eptni1 vl7
13 Dec 23
Full-Year 2024 Revenue Guidance(1) Range of $58.5 to $61.5 Billion Includes Expected Contribution from Seagen Acquisition
7:44am
8-K
dgu5 dh88bu04r3pd
12 Dec 23
Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen
4:35pm
8-K
bj39 x2hr2q3ryr
31 Oct 23
Pfizer Reports Third-Quarter 2023 Results
8:04am
8-K
7okb1 sz2bw0v39xv
13 Oct 23
Pfizer Amends U.S. Government Paxlovid Supply Agreement and Updates Full-Year 2023 Guidance
5:30pm
8-K
4dw918nzv9r9a
1 Aug 23
Pfizer Reports Second-Quarter 2023 Results
8:09am
8-K
tt92f62zmk5bizcz
27 Jul 23
Departure of Directors or Certain Officers
4:11pm
8-K
1chutvltjlgh y4
19 May 23
Other Events
4:26pm
424B5
llp6bjba
18 May 23
Prospectus supplement for primary offering
4:37pm
FWP
uthcx gza
16 May 23
Free writing prospectus
9:31pm
424B3
q2ucptl
15 May 23
Prospectus supplement
7:50am
POSASR
7xue9
15 May 23
Automatic shelf registration (post-effective amendment)
7:40am
8-K
mlrbqaw
15 May 23
Other Events
6:25am
8-K
smobgt34lx0iyk
2 May 23
Pfizer Reports First-Quarter 2023 Results
8:05am
8-K
q1zzv0dl7vikml
1 May 23
Submission of Matters to a Vote of Security Holders
9:39am